Conditions: Angle-closure Glaucoma
Keywords: IOP lowering efficacy CACG
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 30
Healthy volunteers: no

Brief summary:
The purpose of this study is to demonstrate that the Intraocular Pressure (IOP) lowering efficacy of Travoprost Ophthalmic Solution 0.004% is superior to that of Pilocarpine 1% in patients with chronic angle-closure glaucoma (CACG).

Detailed description:

Arms:
arm 1: One drop in each eye, once daily at 9 AM arm 2: One drop in each eye, forth times daily at 7 AM, 11 AM , 4 PM and 9 PM for twelve (12) weeks

Interventions: intervention 1: Travoprost 0.004% (Travatan) intervention 2: Pilocarpine 1%
Intervention descriptions: intervention 1: One drop in each eye, once daily at 9 AM intervention 2: One drop in each eye, forth times daily at 7 AM, 11 AM , 4 PM and 9 PM for twelve (12) weeks

Protocol document: